相似文献
1
Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children.
Indian J Dermatol. 2012 May;57(3):199-200. doi: 10.4103/0019-5154.96192.
2
Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome.
Indian J Dermatol Venereol Leprol. 2008 May-Jun;74(3):238-40. doi: 10.4103/0378-6323.41369.
3
Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
Pediatr Dermatol. 2021 Jul;38(4):812-818. doi: 10.1111/pde.14598. Epub 2021 May 31.
4
Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
J Postgrad Med. 2011 Apr-Jun;57(2):115-9. doi: 10.4103/0022-3859.81865.
5
Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Acta Derm Venereol. 2012 Jan;92(1):62-6. doi: 10.2340/00015555-1169.
6
Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
World J Pediatr. 2017 Jun;13(3):255-260. doi: 10.1007/s12519-016-0057-3. Epub 2016 Sep 20.
7
A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Cureus. 2023 Nov 13;15(11):e48728. doi: 10.7759/cureus.48728. eCollection 2023 Nov.
8
Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Curr Drug Saf. 2022;17(1):40-46. doi: 10.2174/1574886316666210611160123.
9
Retrospective analysis of stevens-johnson syndrome and toxic epidermal necrolysis over a period of 10 years.
Indian J Dermatol. 2011 Jan;56(1):25-9. doi: 10.4103/0019-5154.77546.
10
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Burns. 2020 Jun;46(4):959-969. doi: 10.1016/j.burns.2019.10.008. Epub 2019 Dec 30.
引用本文的文献
1
The Prevalence of Stevens-Johnson Syndrome Complications due to Antiepileptic Drug Use: A Systematic Review and Meta-Analysis.
Int J Prev Med. 2025 Jul 30;16:41. doi: 10.4103/ijpvm.ijpvm_132_24. eCollection 2025.
2
Systemic Medications and Their Ocular Side Effects.
Cureus. 2024 Dec 2;16(12):e74976. doi: 10.7759/cureus.74976. eCollection 2024 Dec.
3
Stevens-Johnson Syndrome From Combined Allopurinol and Angiotensin-Converting Enzyme Inhibitors: A Narrative Review.
Cureus. 2024 Jan 8;16(1):e51899. doi: 10.7759/cureus.51899. eCollection 2024 Jan.
4
Clinical characteristics of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A single-center study.
Asia Pac Allergy. 2022 Apr 21;12(2):e17. doi: 10.5415/apallergy.2022.12.e17. eCollection 2022 Apr.
5
A Life-Threatening Case of Torsemide-Induced Toxic Epidermal Necrolysis Associated With the Treatment of Anasarca.
Cureus. 2022 Mar 6;14(3):e22895. doi: 10.7759/cureus.22895. eCollection 2022 Mar.
6
Drug-related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review.
Indian J Crit Care Med. 2021 May;25(5):575-579. doi: 10.5005/jp-journals-10071-23826.
7
Ocular Side Effects of Systemic Drugs Used in Dermatology.
Indian J Dermatol. 2019 Nov-Dec;64(6):423-430. doi: 10.4103/ijd.IJD_353_18.
8
Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.
JAMA Dermatol. 2017 Jun 1;153(6):514-522. doi: 10.1001/jamadermatol.2016.5668.
本文引用的文献
1
Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children.
J Am Acad Dermatol. 2010 Jan;62(1):54-60. doi: 10.1016/j.jaad.2009.06.085. Epub 2009 Oct 7.
2
Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Pediatrics. 2009 Feb;123(2):e297-304. doi: 10.1542/peds.2008-1923. Epub 2009 Jan 19.
3
Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children.
J Microbiol Immunol Infect. 2004 Dec;37(6):366-70.
4
Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature.
Pediatrics. 2003 Dec;112(6 Pt 1):1430-6. doi: 10.1542/peds.112.6.1430.
5
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.
Drug Saf. 2002;25(13):965-72. doi: 10.2165/00002018-200225130-00006.
6
Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children.
J Am Acad Dermatol. 2002 Oct;47(4):548-52. doi: 10.1067/mjd.2002.127249.
7
Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.
Br J Clin Pharmacol. 2001 Jul;52(1):77-83. doi: 10.1046/j.0306-5251.2001.01407.x.
8
Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
Arch Dermatol. 1993 Jan;129(1):92-6.
9
Clinical pattern of cutaneous drug eruption among children and adolescents in north India.
Pediatr Dermatol. 1995 Jun;12(2):178-83. doi: 10.1111/j.1525-1470.1995.tb00149.x.
Zotero 插件